Literature DB >> 11899428

Blockage of complement regulators in the conjunctiva and within the eye leads to massive inflammation and iritis.

D S Bardenstein1, C J Cheyer, C Lee, E Cocuzzi, M Mizuno, N Okada, M E Medof.   

Abstract

The open environment of the eye is continuously subject to an influx of foreign agents that can activate complement. Decay-accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 are regulators that protect self-cells from autologous complement activation on their surfaces. They are expressed in the eye at unusually high levels but their physiological importance in this site is unstudied. In the rat, a structural analogue termed 5I2 antigen (5I2 Ag) has actions overlapping DAF and MCP. In this investigation, we injected F(ab')2 fragments of 5I2 mAb into the conjunctiva and aqueous humor, in the latter case with and without concomitant blockage of CD59. Massive neutrophilic infiltration of the stroma and iris resulted upon blocking 5I2 Ag activity. Frank necrosis of the iris occurred upon concomitant intraocular blockage of CD59. C3b was identified immunohistochemically, and minimal effects were seen in complement-depleted animals and in those treated with non-relevant antibody. The finding that blockage of 5I2 Ag function in periocular tissues and within the eye causes intense conjunctival inflammation and iritis demonstrates the importance of intrinsic complement regulators in protecting ocular tissues from spontaneous or bystander attack by autologous complement.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11899428      PMCID: PMC1783320          DOI: 10.1046/j.1365-2567.2001.01316.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

Review 1.  The control of homologous lysis.

Authors:  P J Lachmann
Journal:  Immunol Today       Date:  1991-09

2.  Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.

Authors:  M H Holguin; L R Fredrick; N J Bernshaw; L A Wilcox; C J Parker
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

Review 3.  The molecular basis for paroxysmal nocturnal hemoglobinuria.

Authors:  R Yomtovian; G M Prince; M E Medof
Journal:  Transfusion       Date:  1993-10       Impact factor: 3.157

4.  Complement inhibitor of rat cell membrane resembling mouse Crry/p65.

Authors:  H Takizawa; N Okada; H Okada
Journal:  J Immunol       Date:  1994-03-15       Impact factor: 5.422

5.  Localization of decay accelerating factor in normal and diseased kidneys.

Authors:  F G Cosio; D D Sedmak; J D Mahan; N S Nahman
Journal:  Kidney Int       Date:  1989-07       Impact factor: 10.612

6.  Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland.

Authors:  J H Lass; E I Walter; T E Burris; H E Grossniklaus; M I Roat; D L Skelnik; L Needham; M Singer; M E Medof
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-06       Impact factor: 4.799

7.  Differential expression of the complement regulatory proteins in the human eye.

Authors:  N S Bora; C L Gobleman; J P Atkinson; J S Pepose; H J Kaplan
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-12       Impact factor: 4.799

8.  Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement.

Authors:  T R Hughes; S J Piddlesden; J D Williams; R A Harrison; B P Morgan
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

9.  Tissue distribution of complement regulatory membrane proteins in rats.

Authors:  K Funabashi; N Okada; S Matsuo; T Yamamoto; B P Morgan; H Okada
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

10.  A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement.

Authors:  N Okada; R Harada; T Fujita; H Okada
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

View more
  3 in total

1.  The complement anaphylatoxin receptors are not required for the development of experimental autoimmune uveitis.

Authors:  Russell W Read; Susan D Vogt; Scott R Barnum
Journal:  J Neuroimmunol       Date:  2013-08-31       Impact factor: 3.478

2.  Differential gene expression in anatomical compartments of the human eye.

Authors:  Jennifer J Diehn; Maximilian Diehn; Michael F Marmor; Patrick O Brown
Journal:  Genome Biol       Date:  2005-08-17       Impact factor: 13.583

3.  Th1- and Th2-related chemokine and chemokine receptor expression on the ocular surface in endotoxin-induced uveitis.

Authors:  Liem Trinh; Françoise Brignole-Baudouin; Aude Pauly; Hong Liang; Marianne Houssier; Christophe Baudouin
Journal:  Mol Vis       Date:  2008-12-19       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.